STUDY OF A RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUEFACIENS
STUDY OF A RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUEFACIENS
批准号:
3839583
负责人:
R W HARTLEY
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Bacillus Escherichia coli X ray crystallography bacterial genetics bacterial proteins chemical kinetics chemical stability enzyme activity enzyme model enzyme structure enzyme substrate esterase inhibitor gene expression gene induction /repression hydrolysis intermolecular interaction lethal genes molecular cloning mutant nuclear magnetic resonance spectroscopy nucleic acid probes nucleic acid sequence pancreatic ribonuclease plasmids protein biosynthesis protein folding protein sequence recombinant DNA transfection /expression vector
中文摘要
两种蛋白质,芽孢杆菌RNA酶,芽孢杆菌的胞外核糖核酸酶
解淀粉杆菌及其细胞内抑制剂芽孢杆菌素被用作
研究蛋白质折叠和蛋白质-蛋白质的模型系统
交互. Barnase是核糖核酸酶的同源群之一
在原核生物和真核生物中都存在。
重组DNA技术的应用有三个主要目的:(1)
促进野生型和突变体蛋白的产生;(2)检查
基因的结构和控制序列;以及(3)使特异性
改变序列来测试折叠理论和探测芽孢杆菌RNA酶,
barstar互动
克隆的野生型芽孢杆菌RNA酶基因的致死作用可以通过以下抑制:
在同一质粒上表达芽孢杆菌RNA酶抑制剂基因。 E.杆菌质粒
已经为这两种蛋白质设计了载体,
以100 mg的量基本上纯。 DNA和氨基酸序列和x-
两者的射线结构是已知的,并且NMR溶液结构为
barnase 一种合成的荧光底物已被用于研究
水解动力学,并着眼于动力学和稳定性的
天然和突变蛋白质的芽孢杆菌RNA酶-芽孢杆菌RNA酶抑制剂相互作用。 靠近一个
在每种蛋白质中已经产生了数百个定向突变。 一些
这些调查针对的是具体问题,但大多数都是对
蛋白质表面被设计来定位它们的相互作用区域和残基
这两个人都被认为是如此参与。 的两个Cys残基
芽孢杆菌RNA酶抑制剂可以被Ala替代而不丧失活性(体外或体外)。
在体内,但在一定程度上降低了债券的强度)或屈服将
极大地简化了未来对Barstar折叠的研究。 这种替换
Cys残基之一或两者仅降低芽孢杆菌RNA酶抑制剂的稳定性,
在巯基乙醇或DTT存在下测量的野生型的活性。
已经开发了几种方法来测量相对和绝对
芽孢杆菌RNA酶和芽孢杆菌RNA酶抑制剂之间的结合强度
野生型和突变型蛋白质。 对于野生型蛋白质,
解离系数在10到-13的量级。
最近在其他地方的工作中,芽孢杆菌RNA酶基因附着在一个
真核生物启动子,以杀死其中启动子
表达(首先是在植物中产生雄性不育),
引起了人们对它在发育研究中的可能用途的极大兴趣
是多种抗病毒策略的关键
英文摘要
Two proteins, barnase, the extracellular ribonuclease of Bacillus
amyloliquefaciens, and barstar, its intracellular inhibitor, are used as a
model system for the study of protein folding and protein-protein
interactions. Barnase is one of an homologous group of ribonuclease
occurring in both prokaryotes and eukaryotes.
Recombinant DNA techniques are being applied with three major aims: (1) to
facilitate production of wild type and mutant proteins; (2) to examine the
structural and control sequences of the genes; and (3) to make specific
changes in the sequences to test theories of folding and probe the barnase-
barstar interaction.
The lethal effect of the cloned wild type barnase gene can be repressed by
expression of the barstar gene on the same plasmid. E. coli plasmid
vectors have been devised for both proteins and both can now be obtained
essentially pure in 100 mg quantities. DNA and amino acid sequences and x-
ray structures of both are known as well as the NMR solution structure of
barnase. A synthetic fluorescent substrate has been used to study
hydrolysis kinetics and to look at the kinetics and stability of the
barnase-barstar interaction for native and mutant proteins. Close to a
hundred directed mutations in each protein have been produced. Some of
these were aimed at specific questions but most are part of a survey of the
protein surfaces designed to locate their areas of interaction and residues
on both have been identified as being so involved. The two Cys residues of
barstar can both be replaced by Ala without loss of activity (in vitro or
in vivo, but with some reduction in the strength of the bond) or yield will
greatly simplify future studies of barstar folding. Such replacement of
either or both of the Cys residues reduces the stability of barstar only to
that of the wild-type measured in the presence of mercaptoethanol or DTT.
Several methods have been developed for measuring the relative and absolute
strength of the bond between barnase and barstar for various combinations
of wild-type and mutant proteins. For the wild-type proteins the
dissociation coefficient is on the order of 10 to the -13.
Recent work, elsewhere, in which the barnase gene was attached to a
eukaryotic promoter in order to kill the tissue in which that promoter is
expressed (in the first instance to produce male sterility in plants) has
aroused considerable interest in its possible use in developmental studies
and is the key to a variety of anti-viral strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STUDY OF A RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUEFACIENS
-
批准号:5201904
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R W HARTLEY
-
依托单位:
RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUEFACIENS
-
批准号:3875541
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R W HARTLEY
-
依托单位:
STUDY OF A RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUEFACIENS
-
批准号:6161886
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R W HARTLEY
-
依托单位:
RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUENFACIENS
-
批准号:3940232
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R W HARTLEY
-
依托单位:
RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUENFACIENS
-
批准号:4689017
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R W HARTLEY
-
依托单位:
STUDY OF A RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUEFACIENS
-
批准号:2572771
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R W HARTLEY
-
依托单位:
RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUENFACIENS
-
批准号:3917361
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R W HARTLEY
-
依托单位:
RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUENFACIENS
-
批准号:3964011
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R W HARTLEY
-
依托单位:
STUDY OF A RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUEFACIENS
-
批准号:3753948
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R W HARTLEY
-
依托单位:
STUDY OF A RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUEFACIENS
-
批准号:3776059
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R W HARTLEY
-
依托单位:
RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUEFACIENS
-
批准号:3854534
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R W HARTLEY
-
依托单位:
国内基金
海外基金
登录
查看更多内容
重编程L-苏氨酸生产菌株Escherichia coli THRH高效合成L-异亮氨酸的底盘菌株设计与构建
-
批准号:22508213
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:赵振强
-
依托单位:
肠道Escherichia coli BW25113增殖调控C1GALT1介导IgA肾病发生的作用与机制
-
批准号:82470735
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2024
-
负责人:赵晋
-
依托单位:
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
-
批准号:32302245
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:潘寒姁
-
依托单位:
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
-
批准号:82371775
-
项目类别:面上项目
-
资助金额:46万元
-
批准年份:2023
-
负责人:朱慧媛
-
依托单位:
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
-
批准号:31871817
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2018
-
负责人:孙爱东
-
依托单位:
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
-
批准号:81873549
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:刘玉兰
-
依托单位:
高压二氧化碳诱导Escherichia coli O157:H7形成VBNC状态的分子机制
-
批准号:31571933
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:廖小军
-
依托单位:
超高压诱导牛肉中Escherichia coli O157:H7亚致死损伤及其修复研究
-
批准号:31371861
-
项目类别:面上项目
-
资助金额:15.0万元
-
批准年份:2013
-
负责人:江芸
-
依托单位:
高压二氧化碳诱导Escherichia coli O157:H7形成VBNC状态的机制
-
批准号:31371845
-
项目类别:面上项目
-
资助金额:15.0万元
-
批准年份:2013
-
负责人:廖小军
-
依托单位:
高密度二氧化碳致死Escherichia coli的相关蛋白质确证及其结构变化研究
-
批准号:31171774
-
项目类别:面上项目
-
资助金额:66.0万元
-
批准年份:2011
-
负责人:张德权
-
依托单位: